Optimization of the efficiency in an induction machine drive by algorithm based on the interior point method

[EN] This work optimizes the efficiency of the squirrel cage type Inverter-Induction Machine (IM) system, using an algorithm based on the Interior Point Method (IPM), where the input variables are the electromagnetic torque and the rotor speed at steady state,and as outputs the optimal efficiency and slip values are obtained. The optimum rotor flux value is calculated, which is used as a reference in the flux control loop, in the direct control vector method of the IM. Simulation results are obtained where the increase in efficiency is observed in low load states. The experimental installation used in the implementation of the vector control with maximum system efficiency is described, and the experimental results obtained are shown. A discussion is carried out on the results and the use of the Interior Point Optimization Method.[ES] En este trabajo se realiza la optimización de la eficiencia del sistema  Inversor-Máquina de Inducción (MI) del tipo jaula de ardilla, utilizando un algoritmo basado en el Método de Punto Interior (MPI), donde las variables de entrada son el par electromagnético y la velocidad del rotor en estado estacionario, y como salidas se obtienen los valores de la eficiencia óptima y del deslizamiento. Se calcula el valor del flujo óptimo del rotor que se utiliza como referencia en el lazo de control del flujo, en el control vectorial método directo de la MI. Se obtienen resultados de simulación donde se observa el incremento de la eficiencia en estados de baja carga. Se describe la instalación experimental usada en la implementación del control vectorial con máxima eficiencia del sistema, y se muestran los resultados experimentales obtenidos. Se realiza una discusión sobre los resultados y la utilización del Método de Optimización de Punto Interior.Instituto Politécnico Nacional (IPN), proyecto multidisciplinario registro número 1995.Pacheco-Montiel, J.; Badaoui, M.; Rodríguez-Rivas, J.; Alvarado-Farías, JM.; Carranza-Castillo, O.; Ortega-González, R. (2021). Optimización de la eficiencia en el accionamiento de una máquina de inducción mediante algoritmo basado en el método de punto interior. Revista Iberoamericana de Automática e Informática industrial. 18(4):336-346. https://doi.org/10.4995/riai.2020.13418OJS336346184Andréasson, N., Evgrafov, A., Patriksson, M, 2020. An Introduction to Continuous Optimization Fundations & Fundamental Algorithms. Dover Publications.Benson, H. Y., Shanno, D. F, 2014. Interior-point methods for nonconvex nonlinear programming: cubic regularization. Comput Optim Appl, 58:323-346. https://doi.org/10.1007/s10589-013-9626-8Borisevich, A., and Schullerus, G, 2016. Energy Efficient Control of an Induction Machine Under Torque Step Changes. IEEE Trans. on Energy Conv., vol. 31, no. 4, pp. 1295-1303, December. https://doi.org/10.1109/TEC.2016.2561307Capitanescu, F., Wehenkel, L., 2013. Experiments with the interior-point method for solving large scale optimal power flow problems. Electric Power Systems Research, vol. 95, pp. 276-283. https://doi.org/10.1016/j.epsr.2012.10.001Casacio, L., Lyra, C., Oliveira, A.R.L, 2019. Interior point methods for power flow optimization with security constraints. Intl. Trans. in Op. Res. 26 (2019) 364-378. https://doi.org/10.1111/itor.12279Colín, E. A. O., González, I. H. G., Rivas, J. J. R., Castillo, O. C., González, R. O., Caporal, R. M., 2017. Implementación del Algoritmo Sünter-Clare en un Convertidor Matricial 3x3. Revista Iberoamericana de Automática e Informática Industrial (RIAI), vol. 14, no. 4, pp. 446-454, Oct.-Dic. https://doi.org/10.1016/j.riai.2017.06.002De Almeida, A. T., Ferreira, F. J. T. E., Duarte, A. Q, 2014. Technical and Economical Considerations on Super High-Efficiency Three-Phase Motors. IEEE Trans. on Ind. App., vol. 50, no. 2, pp. 1274-1285, March/April. https://doi.org/10.1109/TIA.2013.2272548Eftekhari, S. R., Davari, S. A., Naderi, P., García C., Rodriguez, J, 2020. Robust Loss Minimization for Predictive Direct Torque and Flux Control of an Induction Motor With Electrical Circuit Model. IEEE Trans. on Power Electronics, vol. 35, no. 5, pp. 5417-5426, May. https://doi.org/10.1109/TPEL.2019.2944190Farhat, I. A., El-Hawary, M. E, 2009. Interior point methods application in optimum operational scheduling of electric power systems. IET Generation, Transmission & Distribution, vol. 3, Iss. 11, pp. 1020-1029. https://doi.org/10.1049/iet-gtd.2008.0573IEA International Energy Agency. World Energy Outlook, 2018. IEA, Paris 2018. 01/2020. https://www.iea.org/reports/world-energy-outlook-2018.IEC 60034-30-1, 2014. Efficiency classes of line operated AC motors (IE-code), Edition 1.0.Mallik, S., Mallik, K., Barman, A., Maiti, D., Biswas, S. K., Deb, N. K., Basu, S, 2017. Efficiency and Cost Optimized Design of an Induction Motor Using Generic Algorithm. IEEE Trans. on Ind. Appl., vol. 64, no. 12, pp. 9854-9863, December. https://doi.org/10.1109/TIE.2017.2703687McElveen, R., Melfi, M., McFarland, J, 2019. Improved Characterization of Polyphase Induction Motor Losses: Test Standards Must Be Modified to Improve Efficiency Optimization. IEEE Ind. Appl. Magazine., pp. 61-68, Nov./Dec. https://doi.org/10.1109/MIAS.2018.2875208Rao, N., and Chamund, D, 2014. Calculating Power Losses in an IGBT Module. Application Note. DYNEX Power Control through Innovation.Rathore, A. K., Holtz, J., Boller, T, 2013. Generalized Optimal Pulsewidth Modulation of Multilevel Inverters for Low-Switching-Frequency Control of Medium-Voltage High-Power Industrial AC Drives. IEEE Trans. on Ind. Electronics, vol. 60, no. 10, pp. 4215-4224, Oct. https://doi.org/10.1109/TIE.2012.2217717Seung-Ki, S, 2011. Control of Electric Machine Drive Systems. IEEE Press & Wiley. Printed in the USA.Salomon, C. P., Sant'Ana, W. C., Borges da Silva, L. E., Torres, G. L., Bonaldi, E. L., Olveira, L. E. L., Borges da Silva, J. G, 2015. Induction Motor Efficiency Evaluation Using a New Concept of Stator Resistance. IEEE Trans. on Inst. and Meas., vol. 64, no. 11, pp. 2908-2917, November. https://doi.org/10.1109/TIM.2015.2437632Santos, V. S., Felipe, P. R. V, Sarduy, J. R. G., Lemozy, N. A. L., Jurado, A., Quispe, E. C, 2015. Procedure for Determining Induction Motor Efficiency Working Under Distorted Grid Voltages. IEEE Trans. on Energy Conv., vol. 30, no. 1, pp. 331-339, March. https://doi.org/10.1109/TEC.2014.2335994Shukla, S., and Singh, B, 2017. Solar Powered Sensorless Induction Motor Drive with Improved Efficiency forWater Pumping. IET Power Electronics, vol. 11, issue 3, pp. 1-11, March. https://doi.org/10.1049/iet-pel.2017.0452Stumper, J. F., Dötlinger, A., Kennel, R, 2013. Loss Minimization of Induction Machines in Dynamic Operation. IEEE Trans. on Energy Conv., vol. 28, no. 3, pp. 726-735, September. https://doi.org/10.1109/TEC.2013.2262048Sul, S. K., 2011. Control of Electric Machine Drive Systems. IEEE Press-Wiley & Sons. https://doi.org/10.1002/9780470876541Taheri, A., Rahmati, A., Kaboli, S, 2012. Efficiency Improvement in DTC of Six-Phase Induction Machine by Adaptive Gradient Descent of Flux. IEEE Trans. on Power Electronics, vol. 27, no. 3, pp. 1552-1562, March. https://doi.org/10.1109/TPEL.2011.2163420Vanderbei, R. J., Shanno, D. F, 1999. Interior-point methods for nonconvex nonlinear programming. Computational Optimization and Applications, 13, 31-252. https://doi.org/10.1023/A:1008677427361Vural, A. M, 2015. Interior point-based slack-bus free-power flow solution for balanced islanded microgrids. Int. Trans. Electr. Energ. Syst, 26:968-992. https://doi.org/10.1002/etep.2117Xu, W., Hu, D., Lei, G., Zhu, J, 2019. System-Level Efficiency Optimization of a Linear Induction Motor Drive System. IEEE Trans. on Electrical Machines and Systems, vol. 3, no. 3, pp. 285-291, Sept. https://doi.org/10.30941/CESTEMS.2019.00037Xu, W., Xiao, X., Du, G., Zou, J, 2020. Comprehensive Efficiency Optimization of Linear Induction Motors for Urban Transit. IEEE Trans. on Vehicular Tech., vol. 69, no. 1, pp. 131-139, January. https://doi.org/10.1109/TVT.2019.295395

Clinical Characteristics and Long-term outcomes of patients undergoing combined heart-kidney transplantation: a single-center experience

[Abstract] Background. The purpose of the study was to describe clinical characteristics and long-term survival of patients undergoing combined heart-kidney transplant in a single center. Methods. We conducted a retrospective analysis of 22 consecutive patients who underwent combined heart-kidney transplant at our institution between 1995 and 2013. Long-term outcomes were analyzed by means of the Kaplan-Meier method. Results. Four patients underwent re-do transplant (2 cardiac re-transplants, 1 kidney re-transplant, and 1 combined heart-kidney re-transplant). Most frequent underlying cardiac conditions were coronary artery disease (54%), dilated cardiomyopathy (23%), and chronic rejection of a previous heart graft (18%). Known causes of chronic renal dysfunction were nephroangioesclerosis (23%), drug-related toxicity (14%), and Wegener granulomatosis (5%). Non-specified chronic renal dysfunction was present in 50% patients. In-hospital postoperative mortality rate was 5 of 22 (23%). Causes of early death were directly related to kidney transplant surgery in 4 of 5 (80%) patients. Among the remaining 17 patients who surmounted the postoperative period, long-term survival rates 1 year, 5 years, and 10 years after HKT were 88%, 82%, and 65%, respectively. Over a mean follow-up of 6.7 ± 6.4 years, cumulative incidences of cytomegalovirus infection, coronary allograft vasculopathy, malignancy, and acute cardiac graft rejection were 41%, 6%, 24%, and 41%, respectively. There was no episode of acute renal graft rejection. At the end of follow-up, all survivors (n = 11) were in functional New York Heart Association class I. Mean creatinine serum level was 1.68 mg/dL. Conclusions. In our experience, combined heart-kidney transplant is a feasible therapeutic option that yielded favorable long-term outcomes, with a low cumulative incidence of cardiac graft dysfunction. These results were obtained at the expense of a significant risk of early postoperative mortality, which was mainly related to complications of kidney transplant surgery

Oral Anticoagulation and Risk of Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Mechanical Thrombectomy: Data From the Nordictus Registry

Introduction: We aimed to evaluate if prior oral anticoagulation (OAC) and its type determines a greater risk of symptomatic hemorrhagic transformation in patients with acute ischemic stroke (AIS) subjected to mechanical thrombectomy. Materials and Methods: Consecutive patients with AIS included in the prospective reperfusion registry NORDICTUS, a network of tertiary stroke centers in Northern Spain, from January 2017 to December 2019 were included. Prior use of oral anticoagulants, baseline variables, and international normalized ratio (INR) on admission were recorded. Symptomatic intracranial hemorrhage (sICH) was the primary outcome measure. Secondary outcome was the relation between INR and sICH, and we evaluated mortality and functional outcome at 3 months by modified Rankin scale. We compared patients with and without previous OAC and also considered the type of oral anticoagulants. Results: About 1.455 AIS patients were included, of whom 274 (19%) were on OAC, 193 (70%) on vitamin K antagonists (VKA), and 81 (30%) on direct oral anticoagulants (DOACs). Anticoagulated patients were older and had more comorbidities. Eighty-one (5.6%) developed sICH, which was more frequent in the VKA group, but not in DOAC group. OAC with VKA emerged as a predictor of sICH in a multivariate regression model (OR, 1.89 [95% CI, 1.01–3.51], p = 0.04) and was not related to INR level on admission. Prior VKA use was not associated with worse outcome in the multivariate regression model nor with mortality at 3 months. Conclusions: OAC with VKA, but not with DOACs, was an independent predictor of sICH after mechanical thrombectomy. This excess risk was associated neither with INR value by the time thrombectomy was performed, nor with a worse functional outcome or mortality at 3 months

GWAS for Systemic Sclerosis Identifies Multiple Risk Loci and Highlights Fibrotic and Vasculopathy Pathways

Systemic sclerosis (SSc) is an autoimmune disease that shows one of the highest mortality rates among rheumatic diseases. We perform a large genome-wide association study (GWAS), and meta-analysis with previous GWASs, in 26,679 individuals and identify 27 independent genome-wide associated signals, including 13 new risk loci. The novel associations nearly double the number of genome-wide hits reported for SSc thus far. We define 95% credible sets of less than 5 likely causal variants in 12 loci. Additionally, we identify specific SSc subtype-associated signals. Functional analysis of high-priority variants shows the potential function of SSc signals, with the identification of 43 robust target genes through HiChIP. Our results point towards molecular pathways potentially involved in vasculopathy and fibrosis, two main hallmarks in SSc, and highlight the spectrum of critical cell types for the disease. This work supports a better understanding of the genetic basis of SSc and provides directions for future functional experiments.Funding: This work was supported by Spanish Ministry of Economy and Competitiveness (grant ref. SAF2015-66761-P), Consejeria de Innovacion, Ciencia y Tecnologia, Junta de Andalucía (P12-BIO-1395), Ministerio de Educación, Cultura y Deporte through the program FPU, Juan de la Cierva fellowship (FJCI-2015-24028), Red de Investigación en Inflamación y Enfermadades Reumaticas (RIER) from Instituto de Salud Carlos III (RD16/0012/0013), and Scleroderma Research Foundation and NIH P50-HG007735 (to H.Y.C.). H.Y.C. is an Investigator of the Howard Hughes Medical Institute. PopGen 2.0 is supported by a grant from the German Ministry for Education and Research (01EY1103). M.D.M and S.A. are supported by grant DoD W81XWH-18-1-0423 and DoD W81XWH-16-1-0296, respectively

Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.

Following its emergence in late 2019, the spread of SARS-CoV-21,2 has been tracked by phylogenetic analysis of viral genome sequences in unprecedented detail3–5. Although the virus spread globally in early 2020 before borders closed, intercontinental travel has since been greatly reduced. However, travel within Europe resumed in the summer of 2020. Here we report on a SARS-CoV-2 variant, 20E (EU1), that was identified in Spain in early summer 2020 and subsequently spread across Europe. We find no evidence that this variant has increased transmissibility, but instead demonstrate how rising incidence in Spain, resumption of travel, and lack of effective screening and containment may explain the variant’s success. Despite travel restrictions, we estimate that 20E (EU1) was introduced hundreds of times to European countries by summertime travellers, which is likely to have undermined local efforts to minimize infection with SARS-CoV-2. Our results illustrate how a variant can rapidly become dominant even in the absence of a substantial transmission advantage in favourable epidemiological settings. Genomic surveillance is critical for understanding how travel can affect transmission of SARS-CoV-2, and thus for informing future containment strategies as travel resumes. © 2021, The Author(s), under exclusive licence to Springer Nature Limited

New insights into the genetic etiology of Alzheimer's disease and related dementias

Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele

A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

Abstract: Genome-wide association studies (GWASs) have identified a number of genetic risk loci associated with systemic sclerosis (SSc) and Crohn’s disease (CD), some of which confer susceptibility to both diseases. In order to identify new risk loci shared between these two immune-mediated disorders, we performed a cross-disease meta-analysis including GWAS data from 5,734 SSc patients, 4,588 CD patients and 14,568 controls of European origin. We identified 4 new loci shared between SSc and CD, IL12RB2, IRF1/SLC22A5, STAT3 and an intergenic locus at 6p21.31. Pleiotropic variants within these loci showed opposite allelic effects in the two analysed diseases and all of them showed a significant effect on gene expression. In addition, an enrichment in the IL-12 family and type I interferon signaling pathways was observed among the set of SSc-CD common genetic risk loci. In conclusion, through the first cross-disease meta-analysis of SSc and CD, we identified genetic variants with pleiotropic effects on two clinically distinct immune-mediated disorders. The fact that all these pleiotropic SNPs have opposite allelic effects in SSc and CD reveals the complexity of the molecular mechanisms by which polymorphisms affect diseases

Repositioning of the global epicentre of non-optimal cholesterol

High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk—changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million–4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.</p

Amyotrophic Lateral Sclerosis and Serum Lipid Level Association: A Systematic Review and Meta-Analytic Study

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with unknown etiology. Many metabolic alterations occur during ALS progress and can be used as a method of pre-diagnostic and early diagnosis. Dyslipidemia is one of the physiological changes observed in numerous ALS patients. The aim of this study is to analyze the possible relationship between the rate of disease progression (functional rating scale (ALS-FRS)) and the plasma lipid levels at the early stage of ALS. A systematic review was carried out in July 2022. The search equation was “Triglycerides AND amyotrophic lateral sclerosis” and its variants. Four meta-analyses were performed. Four studies were included in the meta-analysis. No significant differences were observed between the lipid levels (total cholesterol, triglycerides, HDL cholesterol, and LDL cholesterol) and the ALS-FRS score at the onset of the disease. Although the number of studies included in this research was low, the results of this meta-analytic study suggest that there is no clear relationship between the symptoms observed in ALS patients and the plasma lipid levels. An increase in research, as well as an expansion of the geographical area, would be of interest.Junta de Andalucía P20-01061, P18-RT-3324Ministerio de Ciencia e Innovación PID2019-110960GB-I0